322 related articles for article (PubMed ID: 23925000)
1. Development of replication-competent viral vectors for HIV vaccine delivery.
Parks CL; Picker LJ; King CR
Curr Opin HIV AIDS; 2013 Sep; 8(5):402-11. PubMed ID: 23925000
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
3. Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques.
Virnik K; Hockenbury M; Ni Y; Beren J; Pavlakis GN; Felber BK; Berkower I
Retrovirology; 2013 Sep; 10():99. PubMed ID: 24041113
[TBL] [Abstract][Full Text] [Related]
4. Non-replicating viral vector-based AIDS vaccines: interplay between viral vectors and the immune system.
Sauter SL; Rahman A; Muralidhar G
Curr HIV Res; 2005 Apr; 3(2):157-81. PubMed ID: 15853721
[TBL] [Abstract][Full Text] [Related]
5. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
Clarke DK; Hendry RM; Singh V; Rose JK; Seligman SJ; Klug B; Kochhar S; Mac LM; Carbery B; Chen RT;
Vaccine; 2016 Dec; 34(51):6597-6609. PubMed ID: 27395563
[TBL] [Abstract][Full Text] [Related]
6. Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.
Clarke DK; Nasar F; Chong S; Johnson JE; Coleman JW; Lee M; Witko SE; Kotash CS; Abdullah R; Megati S; Luckay A; Nowak B; Lackner A; Price RE; Little P; Kalyan N; Randolf V; Javadian A; Zamb TJ; Parks CL; Egan MA; Eldridge J; Hendry M; Udem SA
J Virol; 2014 Jun; 88(12):6690-701. PubMed ID: 24696472
[TBL] [Abstract][Full Text] [Related]
7. First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
Nyombayire J; Anzala O; Gazzard B; Karita E; Bergin P; Hayes P; Kopycinski J; Omosa-Manyonyi G; Jackson A; Bizimana J; Farah B; Sayeed E; Parks CL; Inoue M; Hironaka T; Hara H; Shu T; Matano T; Dally L; Barin B; Park H; Gilmour J; Lombardo A; Excler JL; Fast P; Laufer DS; Cox JH;
J Infect Dis; 2017 Jan; 215(1):95-104. PubMed ID: 28077588
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.
Egan MA; Chong SY; Rose NF; Megati S; Lopez KJ; Schadeck EB; Johnson JE; Masood A; Piacente P; Druilhet RE; Barras PW; Hasselschwert DL; Reilly P; Mishkin EM; Montefiori DC; Lewis MG; Clarke DK; Hendry RM; Marx PA; Eldridge JH; Udem SA; Israel ZR; Rose JK
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):989-1004. PubMed ID: 15585086
[TBL] [Abstract][Full Text] [Related]
9. Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses.
Seki S; Matano T
Expert Rev Vaccines; 2016; 15(1):119-27. PubMed ID: 26512881
[TBL] [Abstract][Full Text] [Related]
10. Viral vectors as potential HIV-1 vaccines.
Schnell MJ
FEMS Microbiol Lett; 2001 Jun; 200(2):123-9. PubMed ID: 11425463
[TBL] [Abstract][Full Text] [Related]
11. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074
[TBL] [Abstract][Full Text] [Related]
13. A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV).
Shen YJ; Shephard E; Douglass N; Johnston N; Adams C; Williamson C; Williamson AL
Virol J; 2011 May; 8():265. PubMed ID: 21624130
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.
Virnik K; Ni Y; Berkower I
Vaccine; 2013 Apr; 31(17):2119-25. PubMed ID: 23474312
[TBL] [Abstract][Full Text] [Related]
15. Adenoviruses as vectors for HIV vaccines.
Gómez-Román VR; Robert-Guroff M
AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers.
Virnik K; Ni Y; Berkower I
Vaccine; 2012 Aug; 30(37):5453-8. PubMed ID: 22776214
[TBL] [Abstract][Full Text] [Related]
17. The HIV vaccine pipeline, from preclinical to phase III.
Schultz AM; Bradac JA
AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
[No Abstract] [Full Text] [Related]
18. Development of an AIDS vaccine using Sendai virus vectors.
Ishii H; Matano T
Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
[TBL] [Abstract][Full Text] [Related]
19. UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.
Jones BG; Sealy RE; Zhan X; Freiden PJ; Surman SL; Blanchard JL; Hurwitz JL
Vaccine; 2012 May; 30(21):3188-95. PubMed ID: 22425790
[TBL] [Abstract][Full Text] [Related]
20. Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine.
Kuwata T; Miura T; Hayami M
Trends Microbiol; 2001 Oct; 9(10):475-80. PubMed ID: 11597447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
